US7611521078 - Common Stock
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
These S&P500 stocks are moving in today's session
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the S&P500 gap up and gap down stocks in today's session.
Pre-market stock analysis of S&P500 stocks on 2024-04-17: top gainers and losers in today's session.
Why the dividend investor may take a look at RESMED INC (NYSE:RMD).
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the...
These S&P500 stocks are moving in today's session
ResMed announced the results of its 2024 Global Sleep Survey, uncovering a world in sleep crisis and encouraging people to discover their sleep...
ResMed unveils the AirFit F40, an ultra-compact full-face CPAP mask offering the comfort of smaller masks without sacrificing performance. ...
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.
ResMed launched AirCurve 11 bilevel devices to enhance sleep apnea device therapy options....
KeyBanc has resumed coverage of nearly a dozen medtech companies, with Inspire (INSP), Integer (ITGR) and ICU Medical (ICUI) as its top investment ideas. Read more here.
MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent
Philips (PHG) stock falls as it halts sales of its respiratory care devices in the US in a positive to rival ResMed (RMD), says Citi. Read more here.
The medical device maker beat expectations with its latest quarterly results.
ResMed reported better-than-expected sales and adjusted earnings.
ResMed (RMD) declares $0.48/share quarterly dividend, in line with previous. Forward yield 1.12% Payable March 14; for shareholders of record Feb. 8; ex-div Feb
ResMed (RMD) shares jump 9% in after-hours trading as the company reported better-than-expected Q2 results. Read more here.